| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.004 |